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Abstract
Background: Control of malaria is threatened by emerging parasite resistance to artemisinin and derivative drug (ART)
therapies. The molecular detail of how Plasmodium malaria parasites respond to ART and how this could contribute to
resistance are not well understood. To address this question, we performed a transcriptomic study of dihydroartemisinin
(DHA) response in P. falciparum K1 strain and in P. berghei ANKA strain using microarray and RNA-seq technology.
Results: Microarray data from DHA-treated P. falciparum trophozoite stage parasites revealed a response pattern that is
overall less trophozoite-like and more like the other stages of asexual development. A meta-analysis of these data with
previously published data from other ART treatments revealed a set of common differentially expressed genes. Notably,
ribosomal protein genes are down-regulated in response to ART. A similar pattern of trophozoite transcriptomic change
was observed from RNA-seq data. RNA-seq data from DHA-treated P. falciparum rings reveal a more muted response,
although there is considerable overlap of differentially expressed genes with DHA-treated trophozoites. No genes are
differentially expressed in DHA-treated P. falciparum schizonts. The transcriptional response of P. berghei to DHA
treatment in vivo in infected mice is similar to the P. falciparum in vitro culture ring and trophozoite responses, in
which ribosomal protein genes are notably down-regulated.
Conclusions: Ring and trophozoite stage Plasmodium respond to ART by arresting metabolic processes such as protein
synthesis and glycolysis. This response can be protective in rings, as shown by the phenomenon of dormancy. In contrast,
this response is not as protective in trophozoites owing to their commitment to a highly active and vulnerable metabolic
state. The lower metabolic demands of schizonts could explain why they are less sensitive and unresponsive to ART. The
ART response pattern is revealed clearly from RNA-seq data, suggesting that this technology is of great utility for studying
drug response in Plasmodium.
Keywords: Dihydroartemisinin, RNA-seq, Microarray, Plasmodium, Malaria, Transcriptome
* Correspondence: philip@biotec.or.th; sumaleek@biotec.or.th
ˆDeceased
1Protein-Ligand Engineering and Molecular Biology Laboratory, Medical
Molecular Biology Research Unit, National Center for Genetic Engineering
and Biotechnology (BIOTEC), National Science and Technology Development
Agency (NSTDA), 113 Thailand Science Park, Thanon Phahonyothin, Tambon
Khlong Neung, Amphoe, Khlong Luang, Pathum Thani 12120, Thailand
Full list of author information is available at the end of the article
© 2015 Shaw et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Shaw et al. BMC Genomics  (2015) 16:830 
DOI 10.1186/s12864-015-2040-0
Background
Control, and ultimately eradication of malaria require ef-
fective drugs to treat infections. The current most widely-
used artemisinin-based combination therapies are being
undermined by the emergence of resistance in Southeast
Asia. Isolates from different P. falciparum parasite popula-
tions displaying slow clearance in patients possess 10–20
fold greater tolerance to artemisinin and derivatives with
the same pharmacophore (ART) in vitro [1, 2].
Following the completion of the P. falciparum genome
sequence and the development of microarray technology
for interrogating the transcriptome, several studies were
published of parasite transcriptomic response to per-
turbation, including anti-malarial drugs. Whereas para-
site response to some drugs such as antifolates is modest
[3], other drugs, including ART provoke a greater re-
sponse [4, 5]. Greater understanding of the parasite
transcriptional response to ART could give insight into
the drug’s mode of action and the mechanism of para-
site resistance, since ART-resistant parasites display
altered transcriptional programs during the normal
intra-erythrocytic development cycle (IDC), as shown
by microarray analysis of slow-clearance field isolates
[6, 7] and laboratory-induced resistant parasites [8, 9].
Interpretation of the ART transcriptional response is com-
plicated by the fact that sensitivity to this class of drug
varies greatly through the IDC; trophozoites are the most
sensitive, whereas other stages are up to 100-fold less sen-
sitive [10–12]. This variation could correspond with differ-
ent transcriptional responses depending on the stage of
parasite developmental.
A previous microarray study of artesunate response in P.
falciparum trophozoites revealed a major transcriptional
response to the drug [4]. However, the question of whether
other stages of parasite development would respond in a
similar fashion was not addressed, and so it was not clear if
the parasite could respond in a way to counteract the effect
of the drug. Some of the artesunate-induced changes in
gene expression might reflect a protective response by the
parasite, since transgenic over-expression of a tryptophan-
rich protein unique to Plasmodium parasites (previously
identified as over-expressed in response to artesunate [4])
reduces artesunate sensitivity [13].
ART therapy is used to treat P. falciparum and P.
vivax infections, and various ART compounds including
dihydroartemisinin (DHA) are similarly potent against
rodent malaria parasite species such as P. berghei [14].
Given the similarity of drug action against different
Plasmodium species, it is plausible that there is a com-
mon pattern of transcriptional response against this
class of drug. In this study, we explored Plasmodium re-
sponse to ART with the aim of identifying patterns of
gene expression across developmental stages and spe-
cies that could give further insight into mechanism of
drug action. We performed microarray analysis of the
P. falciparum trophozoite DHA response, and per-
formed a meta-analysis of these data together with pub-
lished microarray data for artesunate and artemisinin
responses. The profile of Plasmodium response to DHA
was explored further by RNA-seq analysis of drug-
treated synchronized P. falciparum ring, trophozoite
and schizont cultures and mixed stage P. berghei in
infected mice.
Results
P. falciparum K1 strain response to DHA assessed by
microarray analysis
We tested the transcriptional response to DHA, as this
compound is an active metabolite of ART compounds in
clinical use. The transcriptional response to this compound
was tested for in vitro treatment of P. falciparum K1 using
an experimental design similar to that used previously for
artesunate [4]. Synchronized trophozoite cultures were ex-
posed to therapeutic concentrations of DHA (500 nM) for
1, 2 and 3 h. The transcriptomic changes induced by the
drug were determined by comparing microarray profiles of
drug treated with matched vehicle-treated controls. A
major transcriptional response was observed after 1 h, as
revealed by the 1886 features showing significant differen-
tial expression. After removal of dubious and multiple fea-
tures mapping to the same gene, 1653 differentially
expressed genes were identified. Similar numbers of signifi-
cant features were found for the other treatment time-
points (Additional file 1).
The DHA responses were compared with those reported
for artesunate [4] and artemisinin [5]. On the one hand, we
were not expecting much correspondence among these
datasets since different compounds at different concentra-
tions and treatment regimens were used, parasite strains
were different, and microarraydesigns and protocols dif-
fered. On the other hand, a reproducible set of genes may
be found if drugs with the same pharmacophore provoke a
similar response. From meta-analysis of expression changes
across different treatments, a set of 284 down- and 263 up-
regulated significant genes were found (Additional file 2:
Fig. 1a). Gene ontology (GO) analysis showed significant
enrichment of the terms GO:0043228 ~ non-membrane-
bounded organelle and GO:0043232 ~ intracellular non-
membrane-bounded organelle among down-regulated
genes (FDR = 4.5 %), which primarily relate to the cyto-
plasmic ribosome. No terms were significant among up-
regulated genes. The DHA-induced changes positively
correlated with changes observed during normal ring
and early trophozoite development (0–28 h post infec-
tion (hpi)), whereas drug-induced changes negatively
correlated with mature trophozoite and schizont stages
(30–48 hpi) (Fig. 1b).
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Plasmodium falciparum DHA response assessed by
RNA-seq data analysis
In vitro DHA treatments of P. falciparum K1 were re-
peated (500 nM DHA for 1 h), but this time on
synchronized ring, trophozoite and schizont parasites. The
transcriptomes of the untreated parasite populations
showed maximal correlation with early (10–20 hpi),
mature (24–35 hpi) and late (40–48 hpi) time-points of the
IDC from published RNA-seq studies, respectively (Fig. 2a,
b, c). Drug treatments had no effect on parasite morph-
ology (Additional file 3). The transcriptional responses to
DHA among the different stage parasites were determined
by comparing strand-specific RNA-seq read counts of
drug-treated with matched vehicle-treated controls.
The global profile of transcriptomic changes induced
by DHA for rings and trophozoites were almost mirror-
image profiles of untreated parasites at the same stages
of development (Fig. 2d, e). In contrast, the patterns of
gene expression in DHA-treated schizonts were indistin-
guishable from normal schizont development (Fig. 2f ).
Of the three stages, the most dramatic response was
observed for the trophozoite stage in which 2349 genes
showed significant change. In contrast, 651 genes were
differentially expressed in ring, and none in schizont stage
parasites (Additional file 4). Among the differentially
expressed genes in rings and trophozoites, there was
considerable overlap (Fig. 2g, h). GO analysis showed that
cytosolic ribosome function was strongly represented
among down-regulated genes in rings (Table 1) and
trophozoites (Table 2). Significant GO terms relating to
apicoplast and protein phosphorylation functions were
represented among up-regulated genes in trophozoites
(Table 3).
RNA-seq is a recent, maturing technology which has not
yet been used extensively to study transcriptomic responses
to drugs. We compared data obtained for the P. falciparum
K1 strain trophozoite response from the two transcrip-
tomic approaches. Although many differentially expressed
genes were called as significant, the overlap between
microarray and RNA-seq was rather low, with only 167
down- and 216 up-regulated genes in common (Fig. 3a, b).
To investigate the possible reasons for the discordance
between experimental approaches, the distributions of up-
and down-regulated genes with respect to the average
expression level were determined. For microarray signifi-
cant genes, the distribution of up-and down-regulated
genes is about the same irrespective of the gene expression
level (Fig. 3c). In contrast for RNA-seq, a bias towards up-
regulation is observed for lowest-expressed genes and a
down-regulation bias is apparent for highest expressed
genes (Fig. 3d).
Plasmodium berghei in vivo DHA response assessed by
RNA-seq data analysis
Next, we tested whether the transcriptomic response to
DHA treatment is conserved among Plasmodium parasite
species with similar sensitivity to the drug. Drug treat-






















Fig. 1 Artemisinin and derivative drug (ART) response from microarray
data analysis. a. Heatmap of genes with significant changes in
expression (547 genes FDR < 0.05) by RankProducts meta-analysis
of microarray data for artemisinin [5], artesunate [4] and DHA (this
study) induced changes. Rows correspond to genes and columns
parasite drug treatments. The values used for clustering are the
average of treatment replicates, or the average of multiple probe
measurements for the same gene (Hu et al. data [5]). Columns and
rows were ordered by hierarchical clustering; the row dendrogram is
omitted for clarity. Treatments cluster according to drug derivative/
microarray study, as shown by side bars. b. Correlation of DHA-induced
transcriptional changes (1, 2 and 3 h treatments) in P. falciparum K1
strain with HB3 strain intra-erythrocytic developmental cycle changes
over 46 time-points of hours post-invasion (hpi) [31]. Pearson correlation
coefficients (PCC) were calculated from 4157 shared oligo probe features
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mice. Although P. berghei infections are not synchronous,
parasites in the peripheral animal blood are mostly ring
and trophozoite stages. Given the high degree of overlap in
genes showing a significant change in expression in re-
sponse to DHA between synchronous ring and trophozoite
P. falciparum (Fig. 2g, h; Tables 1, 2, 3), we reasoned that
we would find a similar pattern in terms of DHA-
responsive gene functions in the mixed ring/trophozoite
stage P. berghei. The lack of synchronicity and a suitable
dataset for comparing with changes throughout the IDC






































Fig. 2 Correlation of DHA drug-induced and developmental transcriptional changes from RNA-seq data. RNA-seq data from untreated P. falciparum K1
ring (a), trophozoite (b) and schizont (c) synchronized parasites were compared with published RNA-seq data from time-points taken during the
intra-erythrocytic developmental cycle (IDC) (Bártfai et al. dataset [58], red triangles; Otto et al. dataset [57], blue squares; Siegel et al. dataset [59], open
circles). Pearson correlation coefficients (PCC) were calculated from 3839 genes expressed in all time-points, defined as hours post-invasion (hpi).
Transcriptomic changes in expression induced by 1 h DHA treatment for ring (d), trophozoite (e) and schizont (f) parasites were correlated with
changes during the IDC (data and symbols as in parts A-C). The overlap of genes with significant change in expression under DHA treatment in
ring and trophozoite parasites is shown for down-regulated genes in (g) and up-regulated genes in (h)
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prevented us from determining whether P. berghei also
shows a global arrest response in ring and trophozoite
stages. The strand-specific RNA-seq data from DHA-
treated parasites were compared with vehicle-treated
controls. 87 genes showed significant changes in ex-
pression (Additional file 5). Some of these genes have
no orthologues in P. falciparum, including 14 anno-
tated as exported proteins specific to rodent parasite
species. Of the 68 genes remaining that are orthologous
in P. falciparum, 51 P. falciparum orthologues also
showed significant change in response to DHA in ring
and/or trophozoites (Fig. 4). The majority of these
DHA-responsive genes common between species were
down-regulated. Moreover, cytosolic ribosome function
was significantly represented among these genes by GO
analysis (Table 4).
Discussion
Plasmodium parasite transcriptional responses to the
anti-malarial drug DHA were studied. We performed
Table 1 Gene Ontology analysis of genes down-regulated in response to DHA in P. falciparum K1 rings from RNA-seq analysis
Term Count List Total Pop Hits Pop Total PValue FDR
GO:0006412 ~ translation 70 151 168 1076 1.5E–22 2.0E–19
GO:0044445 ~ cytosolic part 38 115 61 869 3.8E–20 4.3E–17
GO:0005840 ~ ribosome 48 115 108 869 8.3E–18 9.2E–15
GO:0005829 ~ cytosol 42 115 84 869 1.3E–17 1.4E–14
GO:0003735 ~ structural constituent of ribosome 44 184 96 1289 2.4E–14 3.0E–11
GO:0030529 ~ ribonucleoprotein complex 52 115 150 869 7.4E–14 8.2E–11
GO:0005198 ~ structural molecule activity 44 184 115 1289 4.8E–11 6.1E–08
GO:0043228 ~ non-membrane-bounded organelle 49 115 167 869 8.7E–10 9.6E–07
GO:0022627 ~ cytosolic small ribosomal subunit 16 115 22 869 1.9E–09 2.1E–06
GO:0015935 ~ small ribosomal subunit 19 115 35 869 2.5E–08 2.8E–05
GO:0008135 ~ translation factor activity, nucleic acid binding 17 184 47 1289 3.8E–04 4.8E–01
GO:0006006 ~ glucose metabolic process 10 151 20 1076 6.7E–04 9.1E–01
GO:0016052 ~ carbohydrate catabolic process 10 151 21 1076 1.0E–03 1.4E + 00
GO:0044275 ~ cellular carbohydrate catabolic process 10 151 21 1076 1.0E–03 1.4E + 00
GO:0046164 ~ alcohol catabolic process 10 151 21 1076 1.0E–03 1.4E + 00
GO:0005853 ~ eukaryotic translation elongation factor 1 complex 5 115 5 869 1.3E–03 1.4E + 00
GO:0019318 ~ hexose metabolic process 10 151 22 1076 1.6E–03 2.1E + 00
Enrichment of GO terms in 367 significantly down-regulated genes (gene list) was calculated relative to the total of 4075 genes detected as expressed in this stage
(background list). The GO terms listed are those considered significant from DAVID analysis (FDR < 5 %) and non-redundant by REVIGO filtering
Table 2 Gene Ontology analysis of genes down-regulated in response to DHA in P. falciparum K1 trophozoites from RNA-seq analysis
Term Count List Total Pop Hits Pop Total PValue FDR
GO:0005829 ~ cytosol 70 276 85 963 3.4E–26 4.2E–23
GO:0044445 ~ cytosolic part 54 276 62 963 4.6E–22 5.8E–19
GO:0006412 ~ translation 99 348 181 1139 3.1E–13 4.5E–10
GO:0005840 ~ ribosome 68 276 117 963 3.1E–12 3.8E–09
GO:0003735 ~ structural constituent of ribosome 62 407 101 1385 1.4E–11 2.0E–08
GO:0022627 ~ cytosolic small ribosomal subunit 22 276 22 963 3.5E–11 4.3E–08
GO:0030529 ~ ribonucleoprotein complex 82 276 159 963 4.5E–11 5.6E–08
GO:0043228 ~ non-membrane-bounded organelle 87 276 186 963 7.1E–09 8.9E–06
GO:0005198 ~ structural molecule activity 65 407 120 1385 6.6E–09 9.3E–06
GO:0015935 ~ small ribosomal subunit 25 276 35 963 6.5E–07 8.1E–04
GO:0000502 ~ proteasome complex 20 276 30 963 5.9E–05 7.4E–02
GO:0044265 ~ cellular macromolecule catabolic process 29 348 55 1139 9.2E–04 1.3E + 00
Enrichment of GO terms in 1137 significantly down-regulated genes (gene list) was calculated relative to the total of 4636 genes detected as expressed in this
stage (background list). The GO terms listed are those considered significant from DAVID analysis (FDR < 5 %) and non-redundant by REVIGO filtering
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short treatments of drug at high concentration to mimic
what the parasite would have to respond to in a typical
therapeutic intervention. The transcriptional response
to DHA for the P. falciparum K1 strain was first ex-
plored by microarray to permit comparison with other
drug responses at the same trophozoite stage in this
strain. DHA exposure elicits a marked response that is
very similar among the three time-points tested (Fig. 1;
Additional file 1). The majority of trophozoites are in-
viable after 1 h exposure to 500 nM DHA [10]. Therefore,
the consistent transcriptomic pattern of DHA response in
trophozoites is a signature of loss of viability. Moreover,
Table 3 Gene Ontology analysis of genes up-regulated in response to DHA in P. falciparum K1 trophozoites from RNA-seq analysis
Term Count List Total Pop Hits Pop Total PValue FDR
GO:0009536 ~ plastid 122 233 405 963 2.5E–04 0.31
GO:0006468 ~ protein amino acid phosphorylation 25 282 51 1139 3.1E–04 0.45
GO:0020011 ~ apicoplast 121 233 403 963 3.3E–04 0.41
GO:0006793 ~ phosphorus metabolic process 35 282 85 1139 8.4E–04 1.20
GO:0006796 ~ phosphate metabolic process 35 282 85 1139 8.4E–04 1.20
GO:0004674 ~ protein serine/threonine kinase activity 22 353 44 1385 9.6E–04 1.31
GO:0016310 ~ phosphorylation 30 282 70 1139 1.1E–03 1.52
Enrichment of GO terms in 1211 significantly up-regulated genes (gene list) was calculated relative to the total of 4636 genes detected as expressed in this stage
(background list). The GO terms listed are those considered significant from DAVID analysis (FDR < 5 %) and non-redundant by REVIGO filtering
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Fig. 3 Comparison of P. falciparum K1 DHA-responsive genes from microarray and RNA-seq data. The genes identified as showing significant changes in
expression in response to 1 h DHA treatment for P. falciparum K1 trophozoites from microarray (1653 genes) and RNA-seq (2349 genes) experiments were
compared. The overlap of down-regulated genes is shown in (a) and overlap of up-regulated genes in (b). The distributions of DHA-induced change in
expression of differentially expressed genes with respect to average level of gene expression are shown for microarray in (c) and RNA-seq in (d). The log2
(DHA/vehicle) values for 1653 genes from microarray and 2349 genes from RNA-seq were divided equally into 8 intervals of average expression. The
distributions of log2 (DHA/vehicle) values in each interval were determined by beanplot analysis; the mean gene expression change in each interval is
shown by a horizontal line and the distributions of gene expression change are indicated by the “bean” shapes. Wilcoxon rank sum test of these
distributions showed that 3/28 pairwise comparisons in the microarray data are significant (p < 0.05), whereas 21/28 pairwise comparisons in the RNA-seq
data are significant (p < 0.05)
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this pattern is consistent across independent microarray
studies measuring response to different artemisinin deriv-
atives (Fig. 1a). This loss of viability pattern is obscured in
the transcriptomic response to slower acting anti-malarial
drugs such as pyronaridine and chloroquine [15] and anti-
folates [3], perhaps because of confounding transcriptomic
changes occurring through normal cell cycle progression
during the longer drug treatment period needed to ob-
serve a significant transcriptional response.
Correlation analyses of ring and trophozoite DHA treat-
ment profiles with the IDC show that these parasite stages
respond to the drug by global reprogramming of transcrip-
tomes. This is shown most markedly for trophozoites by
the negative correlation between DHA treatment profiles
and mid-cycle IDC time-points corresponding to tropho-
zoite maturation (Figs. 1b and 2e). Apart from a brief early
ring phase, this is the same period during the IDC when
parasites are most vulnerable to DHA [10, 12]. The tran-
scriptome of rings is similarly reprogrammed in that there
is negative correlation of DHA-induced changes with ring
and trophozoite time-points during the IDC (Fig. 2d).
Moreover, there is extensive overlap of differentially
expressed genes induced by DHA between rings and
trophozoites (Fig. 2g, h). The ring and trophozoite tran-
scriptional response to DHA may thus be an arrest
mechanism to retard metabolic processes essential for
maturation, as shown by down-regulation of glycolysis
and protein synthesis genes (Tables 1 and 2). In con-
trast, schizonts do not respond to DHA (Fig. 2f ). The
lack of transcriptional response in schizonts can be ex-
plained by their reduced protein synthesis [16] and
transcription [17]. Moreover, schizonts are also less able
to down-regulate gene expression because of an overall
reduced rate of mRNA decay [18].
The maturation and metabolic status of the cell is critical
in determining sensitivity to ART across other cell types,
since actively dividing mammalian cells are more suscep-
tible to ART-induced cell death than quiescent cells [19].
The arrest transcriptomic pattern in DHA-treated rings
may be a trigger for a physiological protective change, e.g.
dormancy. We did not observe dormant parasites in our
experiments (Additional file 3) as we harvested parasites
immediately after a short treatment period (dormant para-
sites are observed after a 6–13 h lag [10, 12, 20, 21]).
Strains with lower sensitivity to ART are better able to
enter, or recover from dormancy [22–24]. A similar trait
has been observed in parasite isolates from slow-clearing
infections [1, 2] and a rodent malaria model [25], suggest-
ing that in vitro tests of ART response correspond well to
the situation in vivo. In trophozoites, the transcriptional re-
sponse to DHA does not lead to a protective physiological
change, perhaps because parasites at this stage are commit-
ted to an anaplerotic metabolic state in which glycolysis,
TCA cycling and glutamiolysis occur at high rates [26].
The commitment to anaplerosis may occur quite early in
the IDC, since ART-resistant strains are significantly more
tolerant of 700 nM DHA than sensitive strains only for
early ring stages of development [2, 12]. Recently, it has
been shown that ART-resistant clones from slow-clearing
infection isolates have elongated ring and shortened
trophozoite development stages [21]. These adaptations
enhance the parasite’s ability to become a dormant ring
and minimize the ART-vulnerable trophozoite stage.
The arrest response to ART in P. falciparum rings
and trophozoites, perhaps acting as a trigger to prevent
the parasite from maturing, implies that key metabolic
functions (not yet identified) may be disrupted by ART.




























































Fig. 4 DHA-responsive genes conserved among Plasmodium species.
The heatmap shows average DHA-induced changes relative to vehicle
control from two replicates, as determined by limma analysis of RNA-seq
read count data. 51 genes orthologous between P. berghei ANKA and
P. falciparum K1 showed significant change in response to DHA in both
species. The ordering of genes in rows and columns is arbitrary. Genes
with related functions are grouped, as shown by the side-bars. Genes
are labeled by the P. falciparum orthologue gene ID
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because of oxidative damage mediated by interaction of
ART with heme, a major source of molecular iron. Al-
though hemoglobin-heme is highly abundant in the para-
site’s food vacuole, this may not be the major site for the
drug’s killing effect since the ingested content containing
red cell cytosolic proteins such as haemoglobin and cata-
lase can help to detoxify artemisinin [27]. Another site of
parasite heme and molecular iron is the mitochondrion, in
which these cofactors are essential for the functions of cy-
tochromes and iron-sulfur proteins. Although some genes
with mitochondrial function are differentially expressed in
response to DHA, e.g. up-regulation of PF3D7_0915000
(ndh2) and PF3D7_1034400 (sdha) genes in trophozoites
(Additional file 4), there is no concerted regulation of
genes with mitochondrial function as shown by the ab-
sence of related significant GO terms (Tables 1–3). The
lack of a coordinated parasite response regarding mito-
chondrial function suggests that late rings and trophozoites
are committed to mitochondrial biogenesis, which is
perhaps linked to commitment to anaplerosis (see above).
Maturing parasites committed in this manner are vulner-
able to ART because mitochondrial biogenesis exposes the
cell to the oxidative stress effects of ART acting in combin-
ation with heme and molecular iron. The inability of
committed cells to arrest mitochondrial biogenesis imposes
a futile energy expenditure, since mitochondrial function is
ablated by ART (shown by rapid loss of mitochondrial
membrane potential following ART treatment [28, 29]).
Merozoites are less vulnerable to ART [11], because they
are equipped with poorly developed mitochondria and
have low metabolic requirements. Schizonts have low
metabolic requirement and are less sensitive to ART than
trophozoites as they have fully developed mitochondria.
We therefore postulate that maturing parasites committed
to mitochondrial biogenesis are fated to ART-induced
death, whereas young uncommitted cells can become dor-
mant. Our data are thus consistent with the proposal in
[30] that Plasmodium maintains expression of most mito-
chondrial genes, which enables rapid recovery of mitochon-
drial function when exiting from ART-induced dormancy.
Among genes showing significant down-regulation in re-
sponse to DHA in Plasmodium rings and trophozoites, it
is notable that cytosolic ribosome function is represented
among significant GO terms from both microarray and
RNA-seq data (Tables 1, 2 and 4). This coordinated down-
regulation is particularly striking for DHA-treated rings,
since expression of these genes is maximal during the first
20 h of normal development [31]. The coordinated down-
regulation of Plasmodium ribosomal protein genes is not
surprising since they possess a common regulatory elem-
ent in their promoters, the G-box, and putative positive
and negative transcription factors to control their expres-
sions have been described [32]. It is interesting to note that
concerted repression of yeast cytosolic ribosomal protein
genes also occurs under hydrogen peroxide stress, and this
response is dependent on thiol peroxidase enzymes [33].
Plasmodium lack catalase and GPx enzymes, and so they
rely on thiol peroxidase enzymes and the NADPH path-
way for maintaining redox balance [34]. It is tempting to
speculate that thiol peroxidase enzymes become oxidized
under ART stress similar to hydrogen peroxide stress. The
accumulation of these oxidized enzymes could trigger a
peroxide-signalling event [35] that activates the observed
gross transcriptional response in parasites. One potential
regulator of such a peroxide-signalling event is the nuclear
thiol peroxidase PfnPrx, which is essential and has intim-
ate association with most of the parasite genome [36].
Of the significant GO terms among up-regulated
trophozoite genes in response to DHA (Table 3), apico-
plast function was recently shown by qRT-PCR to be
up-regulated in P. falciparum recovering from DHA
treatment; the up-regulation of pyruvate metabolism in
the apicoplast is thought to compensate for reduced
ATP levels caused by down-regulation of glycolysis and
Table 4 Gene Ontology analysis of genes differentially expressed in response to DHA in P. berghei ANKA from RNA-seq analysis
Term Count List Total Pop Hits Pop Total PValue FDR
GO:0043228 ~ non-membrane-bounded organelle 15 21 178 856 2.2E–06 0.002
GO:0043232 ~ intracellular non-membrane-bounded organelle 15 21 178 856 2.2E–06 0.002
GO:0005198 ~ structural molecule activity 11 30 113 1247 1.2E–04 0.121
GO:0003735 ~ structural constituent of ribosome 10 30 95 1247 1.7E–04 0.174
GO:0044445 ~ cytosolic part 8 21 59 856 2.0E–04 0.177
GO:0005829 ~ cytosol 9 21 82 856 2.5E–04 0.220
GO:0015935 ~ small ribosomal subunit 6 21 34 856 7.4E–04 0.658
GO:0022627 ~ cytosolic small ribosomal subunit 5 21 22 856 1.2E–03 1.078
GO:0006412 ~ translation 12 29 168 1023 2.8E–03 3.199
GO:0006096 ~ glycolysis 4 29 13 1023 4.4E–03 4.910
GO analysis was performed using corresponding P. falciparum orthologous genes. Enrichment of GO terms in 68 differentially expressed genes with P. falciparum
orthologues (gene list) was calculated relative to the total of 4084 genes detected as expressed in the P. berghei ANKA samples with P. falciparum orthologues
(background list). The GO terms listed are those considered significant from DAVID analysis (FDR < 5 %) and non-redundant by REVIGO filtering
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TCA cycle [30]. Among the up-regulated genes represent-
ing significant protein phosphorylation GO terms are 18
FIKK kinase genes (Additional file 4). FIKK kinases are
exported to the host red cell and play important roles in
pathogenesis [37, 38]. In accordance with the findings made
by Natalang et al. for artesunate response [4], many other
genes for exported proteins from different families such as
hyp, PHIST, Pfmc-2TM, PfEMP1, RESA, ETRAMP, SUR-
FIN are significantly up-regulated in DHA-treated P. falcip-
arum trophozoites (Additional file 4). The expressions of
Plasmodium translocon of exported proteins (PTEX)
genes recently shown to be essential for protein export
[39, 40] are also significantly up-regulated in DHA-
treated trophozoites (Additional file 4). Increased pro-
tein export may be the final act of dying parasites to
restore the energy deficit, since exported proteins are
essential for uptake of nutrients [40].
Recently, mutations in the PF3D7_1343700 gene encod-
ing K13 protein have been associated with artemisinin re-
sistance in Southeast Asia [41]. Interestingly, this gene is
significantly up-regulated in response to DHA in tropho-
zoites (Additional files 1 and 4). K13 mutations in ART
resistant parasites appear to reduce ubiquitinylation of
proteins, including PfP13K [42]. The expression of the
PfPI3K encoding gene PF3D7_0515300 does not change
in response to DHA (Additional files 1 and 4). The up-
regulation of K13 in response to DHA could reduce
PfP13K protein through the ubiquitin/proteasome path-
way, and in turn lead to reduced phosphatidyl inositol-
3-phosphate (PI(3)P). Reduced PI(3)P could lead to
interference of protein export from the endoplasmic
reticulum (ER), which is dependent on PI(3)P [43].
Interference of protein export would presumably lead to
ER stress, for which P. falciparum is notably vulnerable
[44]. Among the genes with altered expression during nor-
mal development in ART resistant parasites, genes encod-
ing proteins in the unfolded protein response (UPR) are
notably up-regulated [7]. The key genes in this pathway,
i.e. PF3D7_1108600 (ERC), PF3D7_0917900 (HSP70-2 or
BiP), PF3D7_0322000 (CYP19A), PF3D7_1357800 (TCP-
1/cpn60), PF3D7_0306800 (TCP1-b) and PF3D7_0718500
(prefoldin) are significantly down-regulated in P. falcip-
arum ring and/or trophozoites exposed to DHA
(Additional file 4). Furthermore, the P. berghei ortholo-
gues of CYP19A and ERC (PBANKA_121650 and
PBANKA_093840, respectively) are also significantly
down-regulated in response to DHA (Additional file 5).
From these observations, it appears that ART resistant
parasites have adaptations in the arrest transcriptional
response to specifically counteract the ER stress
induced by ART, in particular reversal of expression
changes that could actually sensitize the parasite to
drug. This trend is also apparent for genes with antioxi-
dant function, which are up-regulated in DHA-resistant
parasites to counteract the oxidant stress induced by
the drug [9]. Among genes with known antioxidant
function, the PF3D7_1438900 (thioredoxin peroxidase1),
PF3D7_1457200 (thioredoxin 1), and PF3D7_1121600
(EXP1, an exported glutathione transferase which
mediates sensitivity to artesunate [45]) genes are down-
regulated in response to DHA in P. falciparum trophozo-
ites (Additional file 4) and the orthologues in P. berghei
(Additional file 5).
The in vivo DHA response in P. berghei was strikingly
similar to the ring and trophozoite responses in P. falcip-
arum, as shown by the high correspondence of differentially
expressed orthologous genes from RNA-seq data (Fig. 4)
and with the same significant representation of cytosolic
ribosome function by GO analysis (Table 4). The transcrip-
tional responses between species were similar despite the
fact that the P. berghei were not synchronous and the read
depth was much lower for P. berghei owing to contaminat-
ing mouse mRNA, as shown by the high percentage of
reads mapping to Mus musculus (Additional file 6). This
could mean that the transcriptional response in ring and
trophozoite stages to DHA (see above) is conserved among
Plasmodium parasite species with similar sensitivity to the
drug, although this would need to be investigated further
with synchronous parasites.
Although similar overall patterns of DHA-response in
P. falciparum trophozoites were found among micro-
array and RNA-seq data, there was rather poor agree-
ment in terms of specific genes showing significant
changes in expression (Fig. 3). The P. falciparum micro-
array data analyzed in this study were generated from
two-channel platforms. These data must be normalized
using aggressive techniques such as locally weighted linear
regression to correct for intensity-dependent dye bias due
to differences in physical properties of the two cyanine
fluorescent dyes. Data normalization in this fashion can be
inaccurate though when central assumptions are violated,
for example when a high proportion of genes are differen-
tially expressed, and/or there is a skewed direction of
change in gene expression. In this situation, external RNA
controls may be required [46, 47]. This approach is rarely
used though as it depends crucially on the quality of the
external controls, and appropriate probes for the controls
designed on the array. Normalization of RNA-seq data is
simpler than microarray as it involves re-scaling of global
read counts. In some cases where mRNA content varies
greatly among cell types, external controls may be required
for normalization, as proposed in microarray experiments
[48]. However, the standard Trimmed Mean of M-values
(TMM) normalization method, as we have used in our
RNA-seq experiments, is robust to skewed changes pro-
vided mRNA contents are similar [49]. For the DHA-
responsive genes found by RNA-seq, we found a clear bias
in that highly expressed genes were skewed towards down-
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regulation, and the opposite skew for low-expressed genes.
In contrast, there was no marked bias from normalized
microarray data (Fig. 3). We think that the microarray
normalization procedure removes the skew, which leads to
inaccurate normalization, and consequently inaccuracy in
identification of differentially expressed genes. In contrast,
RNA-seq data normalization is more accurate, as shown by
greater statistical support for differentially expressed genes
and high reproducibility, even among different species.
Conclusions
Our data show that RNA-seq is a powerful tool for identi-
fying the malaria parasite’s response to anti-malarial drugs.
In particular, the arrest response at ring and trophozoite
stages to DHA is clearly evident from RNA-seq data, but is
less obvious from microarray data. As sequencing costs
continue to fall, a far more detailed study than we have
done of the transcriptional response to anti-malarial drug
could be undertaken. In particular, more extensive sam-
pling of drug treatment including parasite starting age,
drug dose and time-point of treatment may reveal the full
complexity of the arrest response employed by the parasite.
This knowledge could lead to more effective use of existing
drugs as we would be able to deploy drugs in combinations
and therapies to circumvent the protective response by the
parasite, and possibly forestall drug resistance.
Methods
Ethics statement
This study was approved by the BIOTEC committee for
use and care of laboratory animals.
P. falciparum K1 parasite culture and microarray
P. falciparum K1 strain was cultured in vitro according to
standard procedures [15, 50]. Parasites cultures were syn-
chronized to ring stages by two consecutive sorbitol treat-
ment cycles [51]. 48 h after the second synchronization,
the parasite culture was divided equally into new culture
plates for drug treatment. The synchronized parasites were
then cultured for 18 h to obtain a majority of trophozoite-
stage parasites for drug treatment. Parasites were treated
with 500 nM DHA (Dafra Pharma, Belgium) or vehicle
solvent control (0.1 % (v/v) DMSO). Parallel culture plates
were left untreated as reference controls. Samples were
taken after 1, 2, and 3 h of treatment. Parasites were har-
vested from culture and liberated from host cells by treat-
ment with 0.15 % (w/v) saponin for 5 min on ice. The
liberated parasites were washed three times with 1xPBS
(137 mM NaCl, 8 mM KCl, 10 mM Na2HPO4, 2 mM
KH2PO4, pH 7.4) to remove host cell debris and drug.
Total RNA was extracted from parasites using Trizol
reagent (Invitrogen) following the manufacturers’ rec-
ommendations. Genomic DNA was removed from total
RNA using a Turbo DNA free™ kit (Ambion, Applied
Biosystems). The RNA was reverse-transcribed to cDNA
using oligo-dT(21) primer, amino-allyl dUTP and Impro-
mII enzyme (Promega), and fluorescent cyanine dye
coupled to amino-allyl labeled cDNA as described in
[52]. cDNA from DHA or vehicle treated parasites was
labeled with Cy5 and culture-matched control untreated
parasite cDNA labeled with Cy3. Approx. 5 pmol of each
Cy-dye labeled cDNA (estimated by NanoDrop ND1000)
was applied to each DNA microarray. The microarray plat-
form containing 8088 70-mer oligo probes was described
previously in [15]. Five independent culture replicate ex-
periments were conducted. Microarray hybridization,
washing and scanning were performed as described in [15].
The images of scanned microarrays were analyzed using
the GenePix Pro 6.1.0.4 package. Microarray feature signals
of irregular shape or with obvious defects, e.g. large dust
specks or scratches were flagged (i.e. marked as not avail-
able for analysis) manually in the GenePix software and
raw data saved in .gpr file format. A total of 29 microarray
hybridizations were performed [53].
RNA-seq library construction
P. falciparum K1 strain was cultured in vitro and
synchronized to ring stages as described above. Parasites
were treated with 500 nM DHA or vehicle solvent
control (0.1 % DMSO), immediately, 18 or 36 h after the
second synchronization, corresponding to ring, tropho-
zoite or schizont populations, respectively. Parallel plates
of parasites from the same synchronized culture were
left untreated as controls. Parasites were harvested from
culture after 1 h of treatment and processed immediately
for RNA extraction.
Plasmodium berghei (ANKA) 507m6cl1 MRA-867 was
obtained through the MR4 as part of the BEI Resources
Repository, NIAID, NIH, deposited by C.J. Janse and
A.P. Waters. 8-week old female ICR mice (approx. 30 g
each) were infected with 1 × 107 P. berghei parasites each
and 24 h post-infection, animals were injected i.p. with
DHA (10 mg/kg) or an equal volume of vehicle control
(30 % DMSO in distilled water). Parasites were obtained
by cardiac puncture 2 h post-injection of drug or vehicle
and harvested in heparinized tubes. White cells were
separated from infected red cells using home-made CF-
11 columns (approx. 4 ml packed resin). The parasitized
red cells were then collected by centrifugation from the
filtered blood. Harvested P. falciparum and P. berghei
were liberated from host cells, total RNA extracted, and
genomic DNA removed as described above.
0.7–4 μg of total RNA from each treatment condition
was converted to a strand-specific RNA-seq sequencing
library using a TruSeq Stranded mRNA LT Sample
Prep kit following the manufacturers’ recommenda-
tions (Illumina). A different TruSeq adapter was used
for each RNA-seq library to allow pooling of samples
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for Illumina sequencing on the same flow cell. Each ex-
periment was performed in duplicate with an independent
parasite culture (P. falciparum), or different infected host
animal (P. berghei). The RNA-seq libraries were quantified
by QuantIT dsDNA High Sensitivity kit (Invitrogen) and
by qPCR using a library quantification kit (Kapa Biosys-
tems). Libraries were pooled in equimolar ratios and
applied to a MiSeq flow cell at 12 pM with 1 % phiX174
control library (Illumina). Paired-end sequencing was per-
formed on two MiSeq v2 2x150 bp flow cells according to
the manufacturers’ recommendations (Illumina). The raw
data from the MiSeq instrument were de-multiplexed and
fastq files generated for each RNA-seq library [53].
Microarray data analysis
Statistical analysis of microarray and RNA-seq data for dif-
ferential gene expression was performed using the limma
package [54] implemented in R 3.0.2. For analysis of micro-
array data from DHA experiments, the .gpr microarray
files were used as input. Microarray features flagged by the
Genepix software, designated as empty (no oligo probe),
not in genome, negative control, positive control, plastid
genome, unmapped, or mapping to non-mRNA were given
zero weight for normalization using the modifyWeights
function in limma. Microarray feature median foreground
signals of Cy5/Cy3 ratios were background corrected with
normexp.offset = 50, and normalized within microarrays by
global loess. Statistical analysis of differences in normalized
Cy5/Cy3 ratio was performed using limma’s linear model
fitting comparing normalized signals of DHA treated/
untreated as one group with vehicle treated/untreated
as another group. Model fitting was performed using
feature weights within each array and across arrays
using array weights. Features with Benjamini-Hochberg
adjusted p-value <0.05 were considered as significant.
For analysis of annotated genes from microarray fea-
tures called significant, we removed all dubious features
that corresponded to defunct gene models, or conflicted
in terms of direction of change for multiple features be-
longing to the same gene model.
Microarray data meta-analysis was performed as follows.
The average log2 normalized values of DHA/vehicle in-
duced change from limma output were obtained for all
features. The published average normalized values for
artesunate versus untreated parasites were obtained from
Natalang et al. Additional file 2 in [4]. From these normal-
ized values, the feature with the lowest reported p-value
from limma statistical testing of differential expression
was taken to represent the annotated gene to which that
probe is designed against. For artemisinin, the published
normalized log2 Cy5/Cy3 values from control treatments
were subtracted from values of corresponding artemisinin
time-points as available from Hu et al. Supplementary
Table 2 in [5]. A data input file was constructed for meta-
analysis containing values for 3196 genes, in which col-
umns contained average normalized values of drug versus
control treatment for different treatment time-points.
Statistical testing of differential gene expression across the
independent datasets was performed using the RPadvance
package from the RankProduct suite [55] in R.3.0.2. Genes
with pfp <0.05 were considered as significant.
Correlation of DHA-induced transcriptomic changes
with those during normal intra-erythrocytic development
(IDC) was performed as follows. The average normalized
fold-change data across 46 IDC time-points for P. falcip-
arum strain HB3 were obtained from the Bozdech et al.
dataset S2 in [31]. These values were log2 transformed and
a data file constructed containing these values and the aver-
age log2 normalized DHA/vehicle values from limma out-
put for the same features (same oligonucleotide probe ID).
Features with missing values were removed leaving 4157
for Pearson correlation analysis.
RNA-seq data analysis
The raw reads from fastq files were first filtered to remove
matches to rRNA by BLAST alignment. Pre-processing
was performed by trimming low-quality base-calls (N)
from reads, followed by removal of exact duplicates and
reads of low overall quality. The pre-processed reads were
mapped to the P. falciparum 3D7 2013-3-1 reference gen-
ome, or P. berghei ANKA 2013-3-1 and Mus musculus
build 38 reference genomes (P. berghei experiments) using
Bowtie2 and TopHat2 programs. Potential duplicate and
inaccurately mapped reads were removed, and gene
expression counts were determined from counts of sense-
strand reads (read 1 only) mapping within (complete and
partial overlap) annotated genes. The RNA-seq data pro-
cessing results are shown in Additional file 6. The full
details of the RNA-seq data processing, including custom
perl scripts are provided in Additional file 7.
The read counts from mapped RNA-seq data were used
as input for limma analysis. Read count data were filtered
to remove non-protein coding genes and genes with read
counts per million <1 in one or more library. The read
counts were normalized using the trimmed mean of M
values function implemented in the edgeR package [49].
The normalized read count data were then used to calcu-
late mean-variance relationships and sample weights in
voom [56]. Tests for differentially expressed genes were
performed using the linear model of DHA versus vehicle
treatment in limma [54]. Genes with Benjamini-Hochberg
adjusted p-value <0.05 were considered as significant.
Correlation analysis of IDC changes with DHA treat-
ment from RNA-seq data was performed in a similar
fashion to microarray as follows. The published RNA-
seq data from IDC time-points [57–59] were obtained
from GEO (Bartfai et al. dataset accession number
GSE23865) and EMBL Bank (ERP000069, Otto et al.
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dataset; and ERP001849, Siegel et al. dataset). The raw
fastq files were processed and mapped to the P. falcip-
arum 3D7 reference genome as described above. The
mapped reads were then used to calculate read counts for
annotated genes. All reads mapping to annotated genes in
the Otto et al. and Bartfai et al. datasets were assumed to
originate from the annotated sense mRNA, whereas only
the mapped sense-strand reads from total RNA libraries
(libraries #1–4) were used for the Siegel et al. dataset. The
sum of read counts from all IDC time-points in each data-
set was used as a reference for determining changes in
gene expression throughout the IDC. The edgeR package
[49] implemented in R.3.0.2 was used to calculate log2
changes in gene expression across IDC time-points, in
which read counts were normalized in each RNA-seq
library using the trimmed-mean of M-values function in
edgeR. The average log2 DHA induced changes from
RNA-seq calculated by limma (see above) were correlated
with log2 IDC changes for genes expressed at read counts
per million >1 in all datasets by Pearson correlation.
Other data analyses
Venn diagrams were made using the VENNY web tool
[60]. Gene ontology analysis was performed using the
database for annotation, visualization, and integrated dis-
covery (DAVID) web tool [61] with default parameters.
The background gene lists comprised all genes with ex-
pression values in each dataset. GO terms with FDR <5 %
were considered as significant. Redundant GO terms from
significant term lists were removed using the REVIGO
tool [62]. Heatmaps and beanplots were constructed using
the R packages heatmap.2 and beanplot, respectively in
R.3.0.2 [63]. Differences in distributions of differentially
expressed genes among ranges of average gene expression
were tested using the Wilcoxon rank sum with Bonferroni
post-hoc test in R.3.0.2 [63].
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